EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects

Bahgat Fayed iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01749-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Bahgat Fayed. Beteiligte Einrichtung: Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, 33 El Boh…. Hauptthemen laut MEDLINE: Biofilms, Antifungal Agents, Nanoparticles, Candida auris. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Centre Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida auris has emerged as a significant global health threat due to its multidrug resistance and ability to form robust biofilms, particularly on medical devices and hospital surfaces. Biofilms protect C. auris from antifungal treatments and the host immune response, making infections persistent and difficult to control. This review explores the potential of nanoparticles to overcome the limitations of traditional antifungal therapies in combating C. auris biofilms. Nanoparticles, with their unique physicochemical properties, offer promising strategies to penetrate biofilm matrices, deliver antifungal agents, and disrupt biofilm structure. Various types of nanoparticles, including metallic, polymeric, lipid-based, and cyclodextrin-based, demonstrate enhanced biofilm penetration and antifungal activity. Their ability to generate reactive oxygen species, disrupt cell adhesion, and release antifungals in a controlled manner makes them ideal candidates for biofilm-targeted therapies. This review presents the current advancements in nanoparticle-based solutions, emphasizing the need for further research into their mechanisms of action, safety, and clinical application. By addressing the challenge of C. auris biofilms specifically, this review provides a critical synthesis of existing knowledge and identifies future directions for developing effective antifungal therapies using nanotechnology. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsAntifungal AgentsNanoparticlesCandida aurisCandidiasisHumansAnimals

Stichwörter der Autor:innen

Antifungal therapyBiofilmMultidrug resistanceNanoparticles

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, 33 El Bohouth Street, P.O. Box 12622, Dokki, Giza, Egypt. bm.ezzat@nrc.sci.eg.

ORCID-Profile: Bahgat Fayed

Förderung

  • National Research Centre Egypt

Zitieren

APA

Fayed, B. (2025). Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01749-w

Vancouver

Fayed B. Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01749-w

BibTeX
@article{Fayed2025,
  author = {Fayed, Bahgat},
  title = {Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01749-w}
}
Kostenlos starten →